Beckman Coulter Life Sciences and Automata announced a strategic partnership to integrate Beckman liquid‑handling and cell analysis instruments into Automata’s LINQ AI‑ready automation platform. The collaboration aims to produce modular, cloud‑orchestrated lab workcells that deliver structured, high‑quality datasets for AI‑driven discovery, and is coupled with Danaher Ventures’ strategic investment and board participation in Automata. Danaher’s involvement and the integrated LINQ ecosystem are positioned to accelerate adoption of autonomous wet‑lab workflows and closed‑loop experimentation in biotech R&D. Companies cited improved workflow reliability, data integrity and scale as immediate goals for customers shifting toward agentic lab automation.